Since the IL2 supplemented media is not sufficient to activate naïve T-cells and IL2 receptor expression is restricted to antigen-activated T-cells, the results suggest that these activated T-cells were already specific to an antigen in the tumour microenvironment [51]. The gene discussed is IL2; the disease is neoplasm.